Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
Plos One
|
March 15, 2024
The impact of metabolic syndrome severity on racial and ethnic disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease
Mohamed I Elsaid, John F P Bridges, Khalid Mumtaz, et al.
Computer Methods and Programs in Biomedicine
|
May 21, 2021
Training of computational algorithms to predict NAFLD activity score and fibrosis stage from liver histopathology slides
Hui Qu, Carlos D Minacapelli, Christopher Tait, et al.
Gastro Hep Advances
|
August 12, 2024
Endoscopic Ultrasound-Guided Liver Biopsy in Clinical Practice
Avik Sarkar, Peter Dellatore, Abhishek Bhurwal, et al.
World Journal of Gastroenterology
|
January 20, 2022
COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations
Abhishek Bhurwal, Carlos D Minacapelli, Evan Orosz, et al.
Journal of Clinical and Translational Hepatology
|
January 16, 2023
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment
Ankoor H Patel, Dhiraj Peddu, Sahil Amin, et al.
Molecular Biomedicine
|
November 27, 2022
Alterations of the fecal microbiota in relation to acute COVID-19 infection and recovery
Yue Sandra Yin, Carlos D Minacapelli, Veenat Parmar, et al.
Gastro Hep Advances
|
August 12, 2024
An Innovative Forum for Gastroenterology and Hepatology Issues
Vinod K Rustgi, Shanthi Srinivasan, Deborah C Rubin, et al.
World Journal of Gastroenterology
|
July 30, 2021
Acute kidney injury and hepatorenal syndrome in cirrhosis
Kapil Gupta, Abhishek Bhurwal, Cindy Law, et al.
Hepatology (Baltimore, Md.)
|
November 3, 2015
Cost-effectiveness of new antiviral regimens for treatment-naïve U.S. veterans with hepatitis C
Alexis P Chidi, Shari Rogal, Cindy L Bryce, et al.
Alimentary Pharmacology & Therapeutics
|
March 28, 2024
Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes
Mohamed I Elsaid, Na Li, Stephen A Firkins, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
Plos One
|
March 15, 2024
The impact of metabolic syndrome severity on racial and ethnic disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease
Mohamed I Elsaid, John F P Bridges, Khalid Mumtaz, et al.
Computer Methods and Programs in Biomedicine
|
May 21, 2021
Training of computational algorithms to predict NAFLD activity score and fibrosis stage from liver histopathology slides
Hui Qu, Carlos D Minacapelli, Christopher Tait, et al.
Gastro Hep Advances
|
August 12, 2024
Endoscopic Ultrasound-Guided Liver Biopsy in Clinical Practice
Avik Sarkar, Peter Dellatore, Abhishek Bhurwal, et al.
World Journal of Gastroenterology
|
January 20, 2022
COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations
Abhishek Bhurwal, Carlos D Minacapelli, Evan Orosz, et al.
Journal of Clinical and Translational Hepatology
|
January 16, 2023
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment
Ankoor H Patel, Dhiraj Peddu, Sahil Amin, et al.
Molecular Biomedicine
|
November 27, 2022
Alterations of the fecal microbiota in relation to acute COVID-19 infection and recovery
Yue Sandra Yin, Carlos D Minacapelli, Veenat Parmar, et al.
Gastro Hep Advances
|
August 12, 2024
An Innovative Forum for Gastroenterology and Hepatology Issues
Vinod K Rustgi, Shanthi Srinivasan, Deborah C Rubin, et al.
World Journal of Gastroenterology
|
July 30, 2021
Acute kidney injury and hepatorenal syndrome in cirrhosis
Kapil Gupta, Abhishek Bhurwal, Cindy Law, et al.
Hepatology (Baltimore, Md.)
|
November 3, 2015
Cost-effectiveness of new antiviral regimens for treatment-naïve U.S. veterans with hepatitis C
Alexis P Chidi, Shari Rogal, Cindy L Bryce, et al.
Alimentary Pharmacology & Therapeutics
|
March 28, 2024
Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes
Mohamed I Elsaid, Na Li, Stephen A Firkins, et al.
Page
of 8